Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity Biotech Investing
